Ipsen Publishes Its Monthly Information Relating to the Total Number of Voting Rights and Shares Making Up Its Issued Capital as at 31 December 2024
Monthly Information Relative to the Total Number of Voting Rights and Shares Composing the Share Capital
In accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers, Ipsen Pharma is required to provide monthly information regarding the total number of voting rights and shares composing its share capital.
Market: Euronext Paris
- ISIN Code: FR 0010259150
- LEI: 549300M6SGDPB4Z94P11
Date: 31 December 2024
Total Number of Shares Composing the Share Capital
As of 31 December 2024, Ipsen Pharma’s share capital consists of:
- Total number of shares: 83,814,526
- Total number of voting rights: 131,939,858 (Gross total) and 130,834,785 (Net total)
Existence of a Statutory Clause Imposing an Obligation to Declare Threshold Crossing
In accordance with Article L.233-8 II of the French Commercial Code, Ipsen Pharma is required to declare any threshold crossing that may occur due to the acquisition or disposal of shares.
Gross Total and Net Total
The Gross total refers to the total number of voting rights attached to the total number of shares, including shares with double voting rights and treasury shares. This total is used as a basis for calculating threshold crossings.
On the other hand, the Net total represents the total number of voting rights attached to the total number of shares, excluding shares without voting rights.
Calculation of Threshold Crossings
When calculating threshold crossings, Ipsen Pharma uses the Gross total as its reference. This ensures that any changes in share ownership are accurately reflected and that all relevant stakeholders are informed.
Declaration Relative to the Total Number of Voting Rights – December 2024
As required by law, Ipsen Pharma is providing a declaration regarding the total number of voting rights and shares composing its share capital as of 31 December 2024. This information is available for viewing in the attachment below:
- Declaration relative to the total number of voting rights – December 2024
By providing this information, Ipsen Pharma aims to maintain transparency and compliance with regulatory requirements.
